kabutan

Medix, Ordinary Profit Forecast for the Fiscal Year Revised Downward by 27%

Tue Feb 10, 2026 3:29 pm JST Earnings

331A Medix Inc. 【J-GAAP】

Earnings Report

Medix Inc. <331A> [TSE Std] announced its financial results in the afternoon session on February 10th (15:29). The consolidated ordinary profit for the cumulative third quarter of the fiscal year ending March 2026 (April to December) decreased 29.4% from the previous period non-consolidated to 456 million yen.

In addition, the full-year forecast for consolidated ordinary profit has decreased 26.7%, from the previous non-consolidated estimate of 832 million yen to 610 million yen.

Based on the full-year plan announced by the company after the downward revision, our estimate of the consolidated ordinary profit for the October to March period (second half) has decreased 37.5%, from the previous non-consolidated estimate of 592 million yen to 370 million yen.

In the most recent three-month period, from October to December (3Q), the consolidated ordinary profit decreased to 216 million yen, a 12.2% decrease compared to the same period last year. The operating profit margin decreased from 23.4% in the same period last year to 20.2%.

Note: Since the third quarter of the current fiscal year, the company has transitioned to consolidated financial statements.

Kabutan News

Actual Results

Accumulated Results 3rd Quarter
Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Progress Rate vs. First Half Announce Accounting Standards
Apr - Dec, 2024 2,997 499 646 596 79.3 67.9 Mar 19, 2025 J-GAAP
Apr - Dec, 2025 2,999 455 456 310 39.6 74.8 Feb 10, 2026 J-GAAP
YoY +0.1% -8.8% -29.4% -48.0% -50.1%

Guidance Update

Second Half Update

Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Adj. Dividend Announce Accounting Standards
Oct - Mar, 2025 Prev 2,450 591 592 414 54.6 15 Nov 11, 2025 J-GAAP
Oct - Mar, 2025 New 2,264 365 370 249 32.9 15 Feb 10, 2026 J-GAAP
Revision Rate -7.6% -38.2% -37.5% -39.9% -39.9%

Full Year Update

Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Adj. Dividend Announce Accounting Standards
Mar, 2026 Prev 4,387 832 832 577 76.1 15 May 13, 2025 J-GAAP
Mar, 2026 New 4,201 606 610 412 54.4 15 Feb 10, 2026 J-GAAP
Revision Rate -4.2% -27.2% -26.7% -28.6% -28.6%

Current Period Guidance

Second Half Results

Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Adj. Dividend Announce Accounting Standards
Oct - Mar, 2024 2,217 549 551 368 48.8 14 May 13, 2025 J-GAAP
Oct - Mar, 2025 Guidance 2,264 365 370 249 32.9 15 Feb 10, 2026 J-GAAP
YoY +2.1% -33.5% -32.8% -32.3% -32.7%

Current Period Guidance

Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Adj. Dividend Announce Accounting Standards
Mar, 2025 4,161 802 951 803 106.5 14 May 13, 2025 J-GAAP
Mar, 2026 Guidance 4,201 606 610 412 54.4 15 Feb 10, 2026 J-GAAP
YoY +1.0% -24.4% -35.9% -48.7% -49.0%

Quarterly Results

Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Operating Profit Margin Announce Accounting Standards
Oct - Dec, 2024 1,053 246 246 161 21.4 23.4 Mar 19, 2025 J-GAAP
Jan - Mar, 2025 1,164 303 305 207 27.5 26.0 May 13, 2025 J-GAAP
Apr - Jun, 2025 961 77 78 53 6.7 8.0 Aug 12, 2025 J-GAAP
Jul - Sep, 2025 976 164 162 110 13.9 16.8 Nov 11, 2025 J-GAAP
Oct - Dec, 2025 1,062 214 216 147 18.8 20.2 Feb 10, 2026 J-GAAP
YoY +0.9% -13.0% -12.2% -8.7% -12.3%

Related Articles